Enasidenib Mesylate and Insulin lispro Subcutaneous
Determining the interaction of Enasidenib Mesylate and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: enasidenib
Brand name: Idhifa, Idhifa
Synonyms: Enasidenib
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Enasidenib Mesylate-Insulin NPH
- Enasidenib Mesylate-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Enasidenib Mesylate-Insulin NPH (Vials)
- Enasidenib Mesylate-Insulin NPH and Insulin Regular
- Enasidenib Mesylate-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Enasidenib Mesylate-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-EnBrace HR
- Insulin lispro Subcutaneous-Enbrel
- Insulin lispro Subcutaneous-Enbrel (Etanercept Prefilled Syringes)
- Insulin lispro Subcutaneous-Enbrel (Etanercept Vials)
- Insulin lispro Subcutaneous-Enbrel SureClick
- Insulin lispro Subcutaneous-Encora